Amit Michaeli

Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel.

GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel.

Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel.

Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel.

Pepticom Ltd. operates as an artificial intelligence platform for peptide discovery. It offers peptide optimization, drug discovery, and small molecule discovery. The company was founded by Anwar Mahmoud Rayan, Amiram Goldblum, Immanuel Lerner and Amit Michaeli in 2011 and is headquartered in Givat-Ram, Israel.